A Phase Ib Clinical Study to Evaluate the Efficacy and Safety of of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
Latest Information Update: 31 Jan 2024
At a glance
- Drugs Catequentinib (Primary) ; Penpulimab (Primary) ; TQB 2618 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
Most Recent Events
- 22 Jan 2024 Status changed from not yet recruiting to recruiting.
- 28 Aug 2023 New trial record